Eli Lilly Operating Income 2010-2025 | LLY

Eli Lilly operating income for the twelve months ending March 31, 2025 was $14.085B, a 88.48% increase year-over-year.

  • Eli Lilly annual operating income for 2024 was $12.899B, a 99.74% increase from 2023.
  • Eli Lilly annual operating income for 2023 was $6.458B, a 9.39% decline from 2022.
  • Eli Lilly annual operating income for 2022 was $7.127B, a 12.12% increase from 2021.

Eli Lilly Operating Income 2010-2025 | LLY

  • Eli Lilly annual operating income for 2024 was $12.899B, a 99.74% increase from 2023.
  • Eli Lilly annual operating income for 2023 was $6.458B, a 9.39% decline from 2022.
  • Eli Lilly annual operating income for 2022 was $7.127B, a 12.12% increase from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B